---
title: "Amylyx Pharmaceuticals (AMLX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/AMLX.US/norm.md"
symbol: "AMLX.US"
name: "Amylyx Pharmaceuticals"
parent: "https://longbridge.com/en/quote/AMLX.US.md"
datetime: "2026-03-10T04:37:45.014Z"
locales:
  - [en](https://longbridge.com/en/quote/AMLX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AMLX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AMLX.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/AMLX.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/AMLX.US/norm.md)


# Amylyx Pharmaceuticals (AMLX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.3004 | -0.3684 | -0.4649 | -0.4190 | -0.5474 |
| ROE | -41.43% | -55.03% | -89.78% | -78.45% | -83.21% |
| Revenue | - | - | - | - | -665000.00 |
| Net income | -33.00M | -34.39M | -41.44M | -35.91M | -37.55M |
| Operating income | -36.60M | -36.03M | -42.86M | -37.80M | -40.65M |
| Gross margin | - | - | - | - | -10792.33% |
| Net margin | - | - | - | - | 5646.02% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 332.64M | 362.74M | 194.60M | 219.68M | 193.63M |
| Leverage | 1.09 | 1.09 | 1.16 | 1.09 | 1.18 |
| BVPS | 2.78 | 3.02 | 1.88 | 2.26 | 2.40 |
| Turnover | - | -0.0022 | -0.0009 | -0.0040 | 0.2457 |
| Cash & STI | 316.98M | 343.99M | 180.83M | 204.07M | 176.50M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 5.49M | 5.88M | 6.26M | 2.07M | 2.73M |
| Net debt | -311.02M | -338.06M | -174.86M | -202.69M | -174.52M |

## Cash Flow Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -27.90M | -30.37M | -25.25M | -39.82M | -59.01M |
| Investing CF | 29.47M | 5.24M | 22.99M | -43.66M | 64.98M |
| Financing CF | -208000.00 | 191.61M | -31000.00 | 65.66M | 110000.00 |
| Free CF | -17.15M | -14.62M | -9.42M | -25.80M | -45.65M |
| OCF coverage | -32445.35% | -126533.33% | -148517.65% | -362036.36% | -162.90% |
| Repaid & issued | -375000.00 | 191.11M | 0.0000 | 65.58M | - |
| CapEx | -86000.00 | -24000.00 | -17000.00 | -11000.00 | -36.22M |